-+ 0.00%
-+ 0.00%
-+ 0.00%

MEDICUS PHARMA INITIATES GROUNDBREAKING PRECISION-E2 PHASE 2A STUDY OF TEVERELIX® IN ENDOMETRIOSIS UTILIZING THE EMIRATI GENOME PROGRAM

Reuters·06/11/2026 11:30:00

Please log in to view news